Dopamine D1 receptor-mediated toxicity in human SK-N-MC neuroblastoma cells

Neurochemistry International

Volumn 48, Issue 3, 2006, Pages 226-234

  Moussa, Charbel E H ^a   Tomita, York ^a   Sidhu, Anita ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Ionic gradient; Metabolism; Mitochondria; NMR; Parkinson's disease

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CYCLIC AMP; CYTOCHROME C; DOPAMINE; DOPAMINE 1 RECEPTOR; POTASSIUM; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POTASSIUM CELL LEVEL; PRIORITY JOURNAL; ANIMAL; CORPUS STRIATUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; METABOLISM; MITOCHONDRION; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGY; RAT; TUMOR CELL LINE;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; CYCLIC AMP; HUMANS; MITOCHONDRIA; NEUROBLASTOMA; RATS; RECEPTORS, DOPAMINE D1;

EID: 30544452245     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2005.09.007     Document Type: Article

References (38)

1. C.M. Anderson, and R.A. Swanson Astrocyte glutamate transport: review of properties, regulation and physiological functions Glia 32 2000 1 14
2. 1 antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia Psychopharmacology (Berlin) 146 1999 328 334
3. 1 agonist SKF 82958 Behav. Pharmacol. 10 1999 175 182
4. Z.I. Alam, S.E. Daniel, A.J. Lees, D.C. Marsden, P. Jenner, and B. Halliwell A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease J. Neurochem. 69 1997 1326 1329
5. +-ATPase of cerebellum granule cells Biochemistry 67 9 2002 1001 1005
6. 13C]Lactate metabolism in the rat brain: an ex-vivo study Proc. Int. Soc. Magn. Reson. Med. 8 2000 1094
7. P.G. Bittar, Y. Charnay, L. Pellerin, C. Bouras, and P.J. Magistretti Selective distribution of lactate dehydrogenase isozymes in neurons and astrocytes of human brain J. Cereb. Blood Flow Metab. 16 1996 1079 1089
8. 1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity J. Biol. Chem. 278 2003 28089 28100
9. D.T. Dexter, C.J. Carter, F.R. Wells, F. Javoy-Agid, Y. Agid, A. Lees, P. Jenner, and C.D. Marsden Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease J. Neurochem. 52 1989 302 306
10. 1 dopamine receptor neurons by pre-mediated site-specific recombination J. Neurosci. 18 1998 9845 9857
11. E. Floor, and M.J. Wertzel Increased protein oxidation in human substantia pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay J. Neurochem. 70 1998 268 275
12. I. Ghorayeb, P.O. Fernagut, I. Aubert, E. Bezard, W. Poewe, G.K. Wenning, and F. Tison Toward a primate model of l-dopa-unresponsive parkinsonism mimicking striatonigral degeneration Movement Disorders 15 2000 531 536
13. +-ATPasse pump activity: correlation with radiation-induced programmed cell death J. Cell Physiol. 171 3 1997 299 304
14. P. Hantraye Modeling dopamine system dysfunction in experimental animals Nucl. Med. Biol. 25 1998 721 728
15. +) induces NADH-dependent superoxide formation and enhances HADH-dependent lipid peroxidation in bovine heart submitochondrial particles Biochem. Biophys. Res. Commun. 170 1990 1049 1055
16. S.Z. Imam, J. El-Yazal, G.D. Newport, Y. Itzhak, J.L. Cadet, W. Slikker Jr., and S.F. Ali Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts Ann. N. Y. Acad. Sci. 939 2001 366 380
17. E. Junn, and M.M. Mouradian Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases J. Neurochem. 78 2001 374 383
18. M. Kitazawa, J.R. Wagner, M.L. Kirby, V. Anantharam, and A.G. Kanthasamy Oxidative stress and mitochondrial-mediated apoptosis in dopaminergic cells exposed to methylcyclopentadienyl manganese tricarbonyl J. Pharmacol. Exp. Ther. 302 2002 26 35
19. J.I. Kourie Interaction of reactive oxygen species with iron transport mechanisms Am. J. Physiol. 275 1 Pt 1 1998 C1 C24
20. J. Lotharius, and K.L. O'Malley The parkinsonism-inducing drug 1-methyl-phenylpyridium triggers intracellular dopamine oxidation: a novel mechanism of toxicity J. Biol. Chem. 275 2000 38581 38588
21. M.J. LaVoie, and T.G. Hastings Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine J. Neurosci. 19 1999 1484 1491
22. C.E. Moussa, C. Wersinger, Y. Tomita, and A. Sidhu Differential cytotoxicity of human wild type and mutant α-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine Biochemistry 43 18 2004 5539 5550
23. M.C. McKenna, J.T. Tildon, J.H. Stevensen, and I.B. Hopkins Energy metabolism in cortical synaptic terminals from wealing and mature rat brain: evidence for multiple compartments of tricarboxylic acid cycle activity Dev. Neurosci. 16 1995 291 300
24. J.M. Medina The role of lactate as an energy substrate for the brain during the early neonatal period Biol. Neonate 48 1985 237 244
25. C.L. Poitry-Yamate, L. Vutskits, and T. Rauen Neurnal-induced and glutamate-dependent activation of glial glutamate transporter function J. Neurochem. 82 4 2002 98 997
26. R.K. Pearce, A. Owen, S. Daniel, P. Jenner, and C.D. Marsden Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease J. Neural Transm. 104 1997 661 667
27. +-pump ATPase by iron-generated free radicals. Protection by 6,7-dimethyl-2,4-DI-1-pyrrolidinyl-7H-pyrrolo[2,3- d]pyrimidine sulfate (U-89843D), a potent, novel, antioxidant/free radical scavenger Biochem. Pharmacol. 51 4 1996 471 476
28. N. Stefanova, Z. Puschban, P.O. Fernagut, E. Brouillet, F. Tison, M. Reindl, K.A. Jellinger, W. Poewe, and G.K. Wenning Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy) Acta Neuropathol. (Berlin) 106 2003 157 166
29. J.P. Spencer, M. Whiteman, P. Jenner, and B. Halliwell 5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons J. Neurochem. 81 2002 122 129
30. S. Stephans, and B. Yamamoto Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity Neuroscience 72 1996 593 600
31. J. Sian, D.T. Dexter, A.J. Lees, S. Daniel, Y. Agid, F. Javoy-Agid, P. Jenner, and C.D. Marsden Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Ann. Neurol. 36 1994 348 355
32. 1 dopamine receptors in a human neuroblastoma cell line Biochem. Biophys. Res. Commun. 166 1990 574 579
33. A. Schurr, C.A. West, and B.M. Rogor Electrophysiology of energy metabolism and neuronal function in the hippocampal slice preparation J. Neurosci. Methods 28 1989 7 13
34. A. Schurr, C.A. West, and B.M. Rigor Lactate-supported synaptic function in the rat hippocampal slice preparation Science 240 1988 1326 1328
35. 1 dopamine receptors and autoxidation Mol. Cell. Neurosci. 25 2004 124 137
36. 13C NMR spectroscopy J. Cereb. Blood Flow Metab. 18 1998 109 117
37. 13C MR spectroscopy Dev. Neurosci. 20 1998 310 321
38. J. Xu, S.Y. Kao, F.J. Lee, W. Song, L.W. Jin, and B.A. Yankner Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson's disease Nat. Med. 8 2002 600 606